Trials in head and neck oncology: Evolution of perioperative adjuvant therapy

Oral Oncol. 2017 Sep:72:80-89. doi: 10.1016/j.oraloncology.2017.07.012. Epub 2017 Jul 15.

Authors

Joseph Zenga¹, Patrik Pipkorn², Douglas R Adkins³, Wade L Thorstad⁴, Brian Nussenbaum²

Affiliations

¹ Massachusetts Eye and Ear Infirmary, Harvard Medical School, Department of Otolaryngology-Head and Neck Surgery, 243 Charles St, Boston, MA 02114, United States. Electronic address: jzenga2@gmail.com.
² Washington University, Department of Otolaryngology-Head and Neck Surgery, United States.
³ Washington University, Department of Medwical Oncology, United States.
⁴ Washington University, Department of Radiation Oncology, United States.

PMID: 28797466
DOI: 10.1016/j.oraloncology.2017.07.012

No abstract available

Publication types

Review

MeSH terms

Chemoradiotherapy
Chemotherapy, Adjuvant
Head and Neck Neoplasms / surgery
Head and Neck Neoplasms / therapy*
Humans
Radiotherapy, Adjuvant
Survival Rate